Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Apyx Medical (APYX) Receivables Refunds (2019 - 2023)

Apyx Medical filings provide 5 years of Receivables Refunds readings, the most recent being $7.8 million for Q2 2023.

  • On a quarterly basis, Receivables Refunds rose 1.44% to $7.8 million in Q2 2023 year-over-year; TTM through Jun 2023 was $7.8 million, a 1.44% increase, with the full-year FY2022 number at $7.5 million, down 1.27% from a year prior.
  • Receivables Refunds hit $7.8 million in Q2 2023 for Apyx Medical, roughly flat from $7.8 million in the prior quarter.
  • In the past five years, Receivables Refunds ranged from a high of $7.8 million in Q1 2023 to a low of $426000.0 in Q4 2019.
  • Median Receivables Refunds over the past 5 years was $7.6 million (2021), compared with a mean of $6.9 million.
  • Biggest five-year swings in Receivables Refunds: skyrocketed 1696.71% in 2020 and later dropped 1.42% in 2022.
  • Apyx Medical's Receivables Refunds stood at $426000.0 in 2019, then skyrocketed by 1696.71% to $7.7 million in 2020, then dropped by 0.16% to $7.6 million in 2021, then decreased by 1.27% to $7.5 million in 2022, then increased by 2.74% to $7.8 million in 2023.
  • The last three reported values for Receivables Refunds were $7.8 million (Q2 2023), $7.8 million (Q1 2023), and $7.5 million (Q4 2022) per Business Quant data.